Cargando…
A review of β-amyloid neuroimaging in Alzheimer's disease
Alzheimer's disease (AD) is the most common cause of dementia worldwide. As advancing age is the greatest risk factor for developing AD, the number of those afflicted is expected to increase markedly with the aging of the world's population. The inability to definitively diagnose AD until...
Autores principales: | Adlard, Paul A., Tran, Bob A., Finkelstein, David I., Desmond, Patricia M., Johnston, Leigh A., Bush, Ashley I., Egan, Gary F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215612/ https://www.ncbi.nlm.nih.gov/pubmed/25400539 http://dx.doi.org/10.3389/fnins.2014.00327 |
Ejemplares similares
-
β-amyloid in biological samples: not all Aβ detection methods are created equal
por: Adlard, Paul A., et al.
Publicado: (2014) -
Interactions of metals and Apolipoprotein E in Alzheimer’s disease
por: Xu, He, et al.
Publicado: (2014) -
Glia and zinc in ageing and Alzheimer’s disease: a mechanism for cognitive decline?
por: Hancock, Sara M., et al.
Publicado: (2014) -
Metals and Alzheimer’s Disease: How Far Have We Come in the Clinic?
por: Adlard, Paul A., et al.
Publicado: (2018) -
In vivo synaptic activity-independent co-uptakes of amyloid β(1–42) and Zn(2+) into dentate granule cells in the normal brain
por: Tamano, Haruna, et al.
Publicado: (2019)